Studies
Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine plus Nab-Paclitaxel and Radiotherapy for Pancreatic Cancer
Cancer
Internal Medicine
Pancreatic Cancer
Adult Subjects
Female Subjects
Male Subjects
The study is a multi-center, open-label, randomized active controlled study of subjects with locally advanced pancreatic adenocarcinoma which is unresectable.